Immunai

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Corporate26 Sep, 2024
***
***
***
Series B27 Oct, 2021
***
***
***
Series A13 Mar, 2020
***
***
***
Seed28 Feb, 2018
***
***
***

*** - To view the data, please log into your account or create a new one.

News related to Immunai8

Filter by
Sort by
Immunai
May 8, 2026 •Show on chart

Israeli-founded AI biotech Immunai expands AstraZeneca cancer ...

New York-headquartered, Israeli-founded AI biotech company Immunai has expanded its collaboration with AstraZeneca in oncology clinical development, ...

https://www.msn.com/en-us/health/other/israeli-founded-ai-biotech-immunai-expands-astrazeneca-cancer-collaboration/ar-AA22DuOd
Immunai
Jan 23, 2026 •Show on chart

Immunai, Bristol Myers Squibb sign AI immune-data collaboration

Immunai is a biotechnology company working to comprehensively map and decode the immune system with single-cell biology and AI to make new therapeutic ...

https://www.msn.com/en-us/health/other/immunai-bristol-myers-squibb-sign-ai-immune-data-collaboration/ar-AA1Uuijn
Immunai
Mar 11, 2025 •Show on chart

Former Pfizer R&D chief Mikael Dolsten joins Immunai's board of ...

Immunai. , a leading artificial intelligence (AI). biotech company. specializing in immune system mapping, has appointed Mikael Dolsten, M.D., Ph.D., ...

https://www.msn.com/en-us/money/companies/former-pfizer-r-d-chief-mikael-dolsten-joins-immunai-s-board-of-directors/ar-AA1Ayny0
Immunai
Nov 15, 2024 •Show on chart

Immunai וטבע ישתפו פעולה בפיתוח תרופות מבוסס AI

חברת הביוטק Immunai, שפיתחה טכנולוגיית AI למיפוי המערכת החיסונית, חתמה על הסכם רב-שנתי עם טבע לפיתוח תרופות בתחומי האימונולוגיה והסרטן בניסויים קליניים....

http://www.msn.com/he-il/news/other/immunai-%D7%95%D7%98%D7%91%D7%A2-%D7%99%D7%A9%D7%AA%D7%A4%D7%95-%D7%A4%D7%A2%D7%95%D7%9C%D7%94-%D7%91%D7%A4%D7%99%D7%AA%D7%95%D7%97-%D7%AA%D7%A8%D7%95%D7%A4%D7%95%D7%AA-%D7%9E%D7%91%D7%95%D7%A1%D7%A1-ai/ar-AA1u5iMo?apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1
Immunai
Sep 27, 2024 •Show on chart

AstraZeneca colabora con Immunai para utilizar la IA en ensayos de ...

AstraZeneca pagará 18 millones de dólares a la empresa de biotecnología Immunai Inc para utilizar el modelo de inteligencia artificial del sistema ...

https://www.msn.com/es-mx/noticias/tecnologia/astrazeneca-colabora-con-immunai-para-utilizar-la-ia-en-ensayos-de-f%C3%A1rmacos-contra-el-c%C3%A1ncer/ar-AA1rh6QT
Show more (3)